Woodmark Pharmacy is a premier institutional pharmacy established in 1993, operating throughout the northeastern U.S. With corporate offices in New York, Massachusetts, and Connecticut, the company extends its coverage across several states in the region, including Rhode Island, New Hampshire, Maine, and Connecticut. Woodmark Pharmacy prides itself on its steadfast dedication to customer support and custom pharmacy programs. Their offerings integrate the latest technologies and detailed reporting, enabling customers to make strategic business decisions with the assistance of their clinical, customer service, and pharmaceutical teams. Woodmark Pharmacy operates in the Health Care and Pharmaceutical industries and is headquartered in the United States. The company has a strong foundation dating back to 1993. As of the latest available information, there is no record of the last investment or the investors involved in the last investment round. However, given their established presence and focus on innovation and customer support, Woodmark Pharmacy presents an intriguing opportunity for potential investors looking to tap into the institutional pharmacy market in the northeastern U.S. In summary, Woodmark Pharmacy has positioned itself as a respected player in the institutional pharmacy space, leveraging technology, dedicated customer support, and custom pharmacy programs to serve its clientele. With its established foundation and a presence in a key geographic region, the company represents an attractive prospect for investors seeking opportunities in the healthcare and pharmaceutical sectors.
There is no investment information
No recent news or press coverage available for Woodmark Pharmacy .